Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Childhood Social Phobia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of social phobia~Exclusion Criteria:~* Pervasive developmental disorders (PDD)~* Schizophrenia~* Major Depression~* IQ of less than 80~* Medical conditions contraindicating use of fluoxetine

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 16 Years
- Healthy Volunteers: t

Study Arms:
- Social Effectiveness Therapy for Children (Type: EXPERIMENTAL): Social Effectiveness Therapy for Children includes social skills training, peer generalization experiences and exposure therapy
- Fluoxetine (Type: EXPERIMENTAL): Fluoxetine given in 10mg doses, up to 40 mg as tolerated
- Pill placebo (Type: PLACEBO_COMPARATOR): Capsules identical to fluoxetine given in 10 mg. doses up to 40 mg.

Based on this trial design, predict the completion outcome and termination type (if applicable).